Chronic

Inflammatory Bowel Disease (IBD)

Inflammatory Bowel Disease (IBD), encompassing Crohn's disease and Ulcerative Colitis, is a journey filled with unique challenges and triumphs. But you're not walking this path alone.

Discover how joining our clinical trial registry can connect you with potentially cutting-edge investigational treatments and a community working towards breakthroughs in IBD care.    Remember, our patient registry is a way to connect you with clinical trials and give you the information you need to discuss further with your healthcare provider and make informed choices about your health.

Featured IBD studies enrolling now.

Enrolling Now.

The Kepler & Webb Studies

Two studies to help advance the treatment for Pediatric Ulcerative Colitis (UC) and Crohn’s Disease (CD) are now enrolling children and teens who have been unresponsive to previous medications.

Enrolling Now.

LATITUDE CD Study

If life with Crohn's disease feels like it revolves around constant planning, pain, and uncertainty, explore a different route with the LATITUDE CD Study.

Enrolling Now.

LATITUDE UC Study

If life with ulcerative colitis feels like it revolves around constant planning, pain, and uncertainty, explore a different route with the LATITUDE UC Study.

Information

Want to go deeper?

Visit Takeda's Clinical Trials Transparency page to get in-depth information on all of Takeda's clinical research trials.

Register Today.

Be in the know.

By joining WeConnect, you will be kept informed of trials that match your health needs so that you can have further conversations with your healthcare provider.

Inflammatory Bowel Disease (IBD)

Understanding Inflammatory Bowel Disease (IBD)

Understanding Inflammatory Bowel Disease (IBD)

Inflammatory Bowel Disease (IBD) encompasses two primary conditions: Crohn's disease and Ulcerative Colitis (UC), both of which are chronic autoimmune disorders affecting the digestive tract. Despite being closely related, Crohn's and UC present unique challenges to those diagnosed, impacting daily life in various ways. With over a million Americans navigating these conditions, understanding IBD is the first step toward effective management.

Causes and Risk Factors

The exact triggers of IBD remain elusive, with scientists pointing to a combination of genetic predispositions and environmental factors. This complex interplay leads the immune system to mistakenly attack the body's own tissues, resulting in inflammation. Crohn's can affect any part of the digestive tract, often involving deep tissue layers, while UC primarily affects the colon's surface lining.

Diagnosing IBD

Diagnosis typically occurs between the ages of 15 and 35 and involves a combination of endoscopic exams, imaging studies, and laboratory tests to differentiate between Crohn's and UC and to assess the extent of inflammation. Early and accurate diagnosis is crucial for implementing effective treatment strategies.

Current Treatment Options for IBD

While there is no cure for Crohn's or UC, a range of treatments exist to manage symptoms and help patients reach and stay in remission. Options include anti-inflammatory drugs, immune system suppressors, and biologics. Treatment plans are highly individualized, often involving a combination of medications along with lifestyle adjustments to control symptoms and maintain quality of life.

Living with Inflammatory Bowel Disease (IBD)

Navigating life with IBD involves more than just managing physical symptoms like abdominal pain, bowel urgency, and fatigue; it also carries a significant emotional toll. The unpredictable nature of flare-ups can cause anxiety and stress, affecting social interactions, work, and personal life. The term "invisible disease" captures the essence of living with Crohn's or UC—though individuals may appear healthy outwardly, they are often grappling with intense internal discomfort and emotional distress.

The journey with IBD is deeply personal, requiring resilience and adaptability. Finding a supportive community, whether through online forums, support groups, or patient networks, can provide comfort and a sense of belonging. Sharing experiences and coping strategies can help alleviate the sense of isolation and empower individuals to lead fulfilling lives despite their condition.

IBD Research and Progress

Ongoing research and clinical trials are the bedrock of progress in treating IBD. Takeda is at the forefront of this effort, committed to developing innovative investigational therapies that offer hope for improved management and eventual cures. By participating in clinical trials through our patient registry, individuals with UC or Crohn's could contribute to the advancement of medical science, paving the way for new treatments and a better understanding of the disease.

Join Our Community in Pioneering Potential Health Solutions

Your experience with IBD is invaluable in the quest for better treatments and ultimately, a cure. By registering with our patient registry, you can stay informed about clinical trials tailored to your condition, joining a collective effort to transform the landscape of IBD care.

Be Part of the Community – Sign up for our Registry Today

Sign up for our patient registry today. Together, we can make a difference.

How WeConnect Works.

Takeda’s patient registry for clinical trials is a breeze to sign up for.

Click the 'Register' button.

Complete a brief contact information form.

Choose your areas of interest.

Look out for a confirmation email.

And just like that—you’re all set!

Now, you can relax while we keep you updated with notifications about Takeda’s clinical trials that might be just the right fit for you.

Keep connecting.

We know you're interested in signing up for Takeda's WeConnect to get direct communication about Takeda clinical trials, but just in case you are looking for other ways to get involved – please review the information below.

Plasma donation.

Plasma-derived therapies are critical, life-saving medicines that many people with rare and complex diseases rely on. Global demand for plasma-derived products, mainly immunoglobulins, has increased dramatically in recent years.

Plasma Donation and BioLife Plasma Services
BioLife Plasma Services is Takeda’s global plasma collection network and an industry leader in the collection of high-quality plasma that is processed into life-saving plasma-based therapies that benefit thousands of people every day.

Learn more about plasma donation and how to help people who require life-saving plasma-based therapies by donating your plasma.

Physician looking to connect?

We at U.S. Medical Affairs at Takeda share your passion for science, evidence-based medicine, and commitment to promoting better health and brighter futures for our patients through potentially innovative medicines.

Our goal is to be readily available to support clinicians and researchers in whatever way we can. We believe the best way to improve disease outcomes is through robust and open communication about the science and clinical evidence.

That’s why we love to hear from medical professionals—to hear your questions, to understand what you’re seeing in the clinic, and to discuss research.

You are encouraged to report side effects or quality issues to Takeda at PVSafetyAmericas@takeda.com. If you prefer, you can report to the Health Authority.

Copyright 2024 Takeda Pharmaceutical Company Limited. All rights reserved.